News
11/23/2020
TKL Research Sold to QuintilesIMS (NYSE:Q)
![](https://dickinsonwilliams.com/wp-content/uploads/2021/03/tomb-tkl.jpg)
TKL Research’s clinical trials division is a full-service, global dermatology specialty clinical research organization (CRO), serving the pharmaceutical, biotechnology, and consumer healthcare industries.